Electroacupuncture treatment for fibromyalgia pain and quality of life
Effect of Electroacupuncture Treatment on Pain, Mechanical Hyperalgesia, Quality of Life and Expression of Mu+ B Cells in Patients With Fibromyalgia: A Prospective Observational Study
This study is testing if electroacupuncture can help people with fibromyalgia feel less pain and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Crete Academic / other |
| Locations | 1 site (Heraklion) |
| Trial ID | NCT05357157 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effects of electroacupuncture on patients diagnosed with fibromyalgia, focusing on pain management, mechanical hyperalgesia, and overall quality of life. It aims to explore the relationship between electroacupuncture treatment and the expression of Mu+ B cells, which may play a role in the condition's pathology. Participants will be monitored for changes in pain levels and other symptoms over a specified period, with a focus on the subjective experience of pain and its management. The study seeks to provide insights into the efficacy of electroacupuncture as a therapeutic option for fibromyalgia.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old with a confirmed diagnosis of fibromyalgia and experiencing widespread pain for more than six months.
Not a fit: Patients with deep depression, systemic infections, or those using biological agents like TNF inhibitors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could offer a new, effective treatment option for managing chronic pain in fibromyalgia patients.
How similar studies have performed: Previous studies have shown promising results with acupuncture and electroacupuncture in managing chronic pain conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient's consent * Age \>18 years old * Patients with diagnosed fibromyalgia from rheumatologists * Widespread pain more than 6 months * In case of drug therapy, it should be taken at least one month before the beginning of the session and remain stable till the end of the study Exclusion Criteria: * Deep depression * Biological agent use ( TNF inhibitors) * Heamatological diseases * Systemic Infections * pregnancy * electroacupuncture contraindications (epilepsy, pacemaker/ implantable cardioverter defibrillator (ICD)
Where this trial is running
Heraklion
- University Hospital of Heraklion — Heraklion, Greece (Recruiting)
Study contacts
- Study coordinator: Vasileia Nyktari
- Email: vnyktari@gmaill.com
- Phone: +302810392994
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.